The aryl hydrocarbon receptor (AHR) mediates the toxicity of a variety of environmental chemicals. Apart from this, an understanding is emerging that the AHR has a fundamental role in female reproduction. Evidence suggests that AHR participates in regulation of follicle-stimulating hormone receptor (Fshr) transcript level in mouse ovary by binding to the promoter of this gene in vivo. The purpose of this study was to demonstrate the molecular interplay of the Fshr promoter involved in the transactivation by AHR in mouse granulosa cells. We found that AHR activates the Fshr promoter through the region from À209 to À99 bp. In this region, the importance of the E-box motif was revealed by site-directed mutagenesis followed by promoter analysis. By focusing on the DNA/protein interactions, we defined the fact that the intact E-box but not upstream transcription factor 1 (USF1), which is known to bind this motif, is necessary for AHR binding to mouse Fshr promoter. Furthermore, by constructing AHR mutants defective in DNA interaction, we confirmed the importance of DNA binding for AHR's ability to bind to and activate Fshr promoter. Collectively, the present study demonstrates that AHR modulates Fshr transactivation by its direct association through an E-box and not by recruitment via interaction with USFs. These observations suggest that although AHR and USF may respond to different signals, they compete on binding to the same E-box. Our data, together with that from one prior study suggesting involvement of E-box motif in AHR-mediated transcription, provide novel understanding of the way in which AHR may regulate its target genes through E-box sites.
INTRODUCTION
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor belonging to basic helix-loop-helix (bHLH)/Per-Arnt-Sim (PAS) family that controls the expression of a diverse set of genes, including those encoding xenobiotic metabolizing enzymes [1] . According to wellestablished activation mechanism, in a latent state, AHR exists in the cytoplasm in a complex with molecular chaperones. Upon ligand binding, the AHR translocates into the nucleus, where it forms a heterodimer with its partner, the AHR nuclear translocator (ARNT) protein, already present in the nucleus, and the newly formed AHR/ARNT heterodimer binds to the xenobiotic response elements (XREs) (with core consensus sequence 5 0 -TNGCGTG-3 0 ) located in the 5 0 flanking region of the target genes [2] .
For several decades, the AHR has been known as an intracellular mediator of toxicity caused by polychlorinated dioxins and related compounds because binding of these toxicants to the AHR initiates a cascade of events that often leads to toxicity, including teratogenesis, immune suppression, tumor promotion, and liver damage [3] . The most definitive evidence comes from studies with AHR knockout (Ahr KO) mice, which have proved to be unresponsive to all major effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) [4] , the highest affinity ligand and most potent inducer of AHRmediated genes.
Until very recently, there has been little or no insight into the role the AHR might play in normal physiological homeostasis [5] . Importantly, an understanding has started to emerge that knocking down the AHR leads to decreased fertility in female mice, suggesting its fundamental role in female reproductive function [6] . Specifically, there are studies that indicate that AHR-deficient female mice exhibit difficulties maintaining conceptuses during pregnancy [7] , a decreased number of antral follicles [8] , slower follicular growth [9] , and a reduced number of corpora lutea compared to wild-type female mice ovaries [10] , which suggests that Ahr KO mice have a lowered capacity to ovulate.
A recent publication by Barnett and colleagues [11] has contributed to our knowledge of the mechanism behind this effect, showing that AHR deletion regulates ovulation by altering follicle-stimulating hormone (FSH) and luteinizing hormone (LH) receptor transcript levels in the ovary and thus decreasing gonadotropin responsiveness. FSH and its relative, LH, are major components of the hypothalamic-pituitary-gonad axis, which regulates reproductive function and ultimately the production of gametes and fertility [12] . By binding FSH receptor (FSHR) located on the membrane of ovarian granulosa cells, FSH promotes the development of immature follicles, eventually leading to the formation of mature preovulatory follicles [13, 14] .
As to how AHR contributes to Fshr expression, further evidence by Barnett et al [11] showed that AHR interacts with the promoter regions of the Fshr in vivo and thus may directly regulate Fshr transcription in mice. However, no information was presented in that study to delineate the precise model by which the AHR participates in Fshr promoter activity. This is of special interest as there are no classical AHR binding sites (XREs) present in Fshr promoter sequence.
Transcriptional studies of the Fshr gene have focused predominantly on its 5 0 flanking or promoter region and have identified various regulatory elements and proteins important for promoter activity [12] , including an E-box upstreamactivating sequence (CANNTG) and an initiator region conserved in rat, human, and mouse. In mouse, regulatory elements that sustain the basal promoter activity are present within the sequence between nucleotides À555 and À99 bp [15] . Furthermore, binding of upstream transcription factor 1 Supported by Estonian Science Foundation grant 7839. 2 Correspondence: E-mail: tarmo.tiido@ut.ee (USF) homodimers or heterodimers to its DNA element, the Ebox is required for transcriptional regulation of mouse Fshr, as shown both by in vitro and in vivo studies [16] .
Because the AHR transactivation of Fshr promoter has never been scrutinized in detail, the aim of the current study was to characterize which cis-acting elements and/or trans factors contribute to this regulation in vitro. In this study, we used constitutively active AHR (CA-AHR), which lacks the ligand-binding domain and has constitutive activity, to show that E-box contributes to AHR-dependent Fshr transactivity. Our data suggest no requirement of USF1 for binding of AHR to the Fshr promoter at E-box. 
MATERIALS AND METHODS

Media
Reporter Constructs for the Fshr Promoter
The 5 0 flanking region in the mouse Fshr promoter, from À1553 to À1 bp (all numbering is relative to the translation start site), was generated by PCR using 2.5 U of High Fidelity PCR Enzyme Mix (Fermentas, Vilnius, Lithuania) and a final concentration of 200 lM of each deoxyribonucleotide triphosphate (Fermentas), 200 nM of each primer (FSHR-1553_For and FSHR-1_Rev; Metabion, Martinsried, Germany), and 1 lg of genomic DNA as template in a 50-ll PCR reaction. Primers for these PCR reactions were designed based on GenBank sequence NT_039649.7 and are presented in Table 1 . The cycling protocol was initial denaturation at 948C for 3 min, followed by 30 cycles of 948C for 1 min, 558C for 1 min, and 728C for 2 min, with a final extension at 728C for 10 min. The PCR products and the pGL3-Basic luciferase vector (Promega, Madison, WI) were digested with KpnI and XhoI (Fermentas) at 378C for 1 h and purified with NucleoSpin Extract II kit (Macherey-Nagel, Düren, Germany), either by PCR cleanup or gel extraction. Purified PCR product was ligated into digested pGL3-Basic vector using 2.5 U of T4 DNA ligase (Fermentas) in a 20-ll reaction mixture at 228C for 2 h. Plasmids were initially prepared from overnight cultures of Escherichia coli strain DH5a by using plasmid QuickPure Miniprep kit (Macherey-Nagel) and then purified with a NucleoBond Xtra Midi Kit (Macherey-Nagel). The 1553-bp FSHR construct (1 ng) was used as template for all subsequent PCRs to generate the FSHR serial deletion constructs (562/À1-LUC, 209/À1-LUC, and 99/À1-LUC, with the start and end of each construct shown relative to the translation start site) using primers shown in Table 1 , with PCR conditions similar to those listed above. All constructs were sequenced for verification of the correct insert at the Core Laboratory of DNA Genotyping and Sequencing at IMCB of the University of Tartu.
Expression Vectors
The expression plasmid for the CA-AHR, consisting of the mutant AHR lacking the minimal PAS B motif, was generated by PCR cloning as described previously [17] . All primers (Table 1) were chosen based on the cDNA sequence of mouse Ahr (GenBank accession number NM_013464.4). First, pcDNAI/B6AHR containing full-length murine Ahr cDNA [18] (provided by Dr. A. Puga, University of Cincinnati, OH) was amplified using primers designed to yield a fragment of the AHR gene encoding codons 1-287. Primers (AHR1-287_For and AHR1-287_Rev) were designed to carry restriction sites for HindIII and XhoI, enabling directional insertion into HindIII/XhoI-digested pGEM-7Zf (þ) (Promega) to give AHR1-287/GEM. An AHR fragment encompassing codons 422-805 was obtained by PCR from pcDNAI/B6AHR, using specific primers (AHR422-805_For and AHR422-805_Rev) carrying restriction sites for XhoI. The resulting fragment was digested with XhoI and subcloned into XhoI-digested pAHR1-287/GEM to give pCA-AHR/GEM. All constructs were confirmed by DNA sequence analysis. HindIII/XbaI digestion of the pCA-AHR/GEM construct followed by subcloning into HindIII/XbaIdigested eukaryotic expression plasmid pcDNA3.1/Zeo (þ) (Invitrogen, Paisley, U.K.) yielded CA-AHR. The plasmid pAhRDtkLuc3 [18] , which contains the firefly luciferase reporter under the control of a thymidine kinase minimal promoter regulated by three XREs from the murine Cyp1a1 promoter, was a gift from Dr. A. Puga (University of Cincinnati, OH). Expression construct pcDNAI/Neo/mARNT [19] for mouse ARNT was obtained from Dr. O. Hankinson (University of California, CA).
Mutagenesis
Mutations in the transcription factor-binding sites of the Fshr promoterreporter constructs were carried out using the Change-IT site-directed mutagenesis kit (USB, Cleveland, OH) and oligonucleotides listed in Table 1 TEINO ET AL.
according to the supplier's recommendations. Briefly, both strands of the FSHR À209/-1 plasmid were replicated by PCR using FideliTaq DNA polymerase (USB) with a pair of 5 0 -phosphorylated nonoverlapping primers, one of which was designed to introduce the desired mutation (either FSHR_E-box mt, FSHR_AP-1 mt, or FSHR_XRE mt), and Amp FWD (5 0 -CCATGAGTGA-TAACACTGCGGCCAACTTACTTCTGAC-3 0 ) as a universal primer (the latter was provided as part of the components in the Change-IT kit). The PCR conditions were 25 cycles of denaturing at 958C for 30 sec, annealing at 588C for 30 sec, and extension at 688C for 12 min. The parental DNA template was digested by adding 1 ll of DpnI restriction enzyme for 2 h at 378C. Three microliters of the PCR reaction mixture was used to transform E. coli DH5a competent cells. Plasmids from several isolated colonies were prepared with the plasmid QuickPure miniprep kit (Macherey-Nagel, Düren, Germany). In all cases, the resulting clones were subjected to sequence analysis. Two mutations of the wild-type Ahr cDNA, the replacement of GCC coding for alanine (A) at residue 78 with GAC coding for aspartate (D), and insertion of nucleotides GGATCC, coding for amino acids glycine and serine, between arginine-39 and aspartate-40, resulted in AHR protein not capable of DNA binding [20, 21] ; these modifications, designated AHR_A78D and AHR_DBD, respectively, were introduced into the CA-AHR expression vector by using the same protocol as described above, except that AHR_A78D mt and AHR_DBD mt, respectively, were applied as mutagenic primers.
Animals and Granulosa Cell Culture
Mice used in this study were housed in a pathogen-free animal facility at our institute under continuously monitored room temperature and humidity in a controlled 12L:12D cycle with food and water continuously available. All animal procedures were conducted in compliance with Estonian Law of Animal Protection and upon approval of the protocol by the Licensing Committee of Animal Experiments at Estonian Ministry of Agriculture. In our experiments, we used 20-to 22-day-old C57BL/6J female mice primed with an intraperitoneal injection of 5 IU of equine chronic gonadotropin (Intervet, Boxmeer, Netherlands). Approximately 44 h later, animals were euthanized, and ovaries were removed and dissected free of connective tissue. Granulosa cells were isolated and cultured by using previously described techniques with modifications [22] . Briefly, ovaries were washed in cold DMEM/Ham F-12 medium and then transferred to a tube containing preincubation medium (0.5 M sucrose and 10 mM ethylene glycol tetraacetic acid in DMEM/Ham F-12), and incubated at 378C in 5% CO 2 in air in a humidified atmosphere until the ovaries gravitated to the bottom of the tube. To obtain granulosa cells, we punctured follicles with 26-guage needles under microscopic visualization, and thereafter, the released cells were pelleted and resuspended in DMEM/Ham F-12 medium. After cells were washed in the same medium, the cells were subsequently seeded in DMEM/Ham F-12 medium supplemented with a solution of 10% FBS, 13 antibiotic-antimycotic agent, and 13 nonessential amino acids on 60-mm dishes precoated with 1 lg/cm 2 human fibronectin (354008; BD Biosciences, Bedford, MA). Cultures were maintained at 378C in a humidified chamber with 5% carbon dioxide. On the following day, medium was changed in order to remove nonattached cells and cell debris. After 2 days of culture, 5 3 10 4 cells were seeded in each well of 24-well plates (for transient transfections) or lysed (for DNA affinity precipitation assay) as described below.
Transient Transfections and Reporter Gene Assay
In this study, the KK-1 cell line was used along with primary cultures of mouse granulosa cells to assay reporter gene activity. The KK-1 cells were derived from a granulosa cell tumor of a transgenic mouse expressing simian virus 40 (SV40) T antigen under the murine inhibin a-subunit promoter [23] . These cells were a generous gift from Prof. Ilpo Huhtaniemi (Imperial College London, U.K.) and were routinely cultured in DMEM/Ham F-12 medium containing 10% FBS, 13 antibiotic-antimycotic agent, and 13 nonessential amino acids. For transient transfections in the KK-1 line, 4.5 3 10 4 cells per well were seeded on 24-well plates prior to the day they were used so that they would reach 60-70% confluence. For experiments that included AHR's activation by ligand, 10 nM TCDD was added to the culture medium either 24 h before transfection, at transfection, or 24 h after transfection and kept in cell medium until the luciferase reporter assay was to be performed. Control samples received an equal volume of the vehicle DMSO alone at a final concentration never exceeding 0.1%. All transient cotransfection experiments for luciferase reporter assays were carried out three times with duplicate wells for each experiment using 600 ng of each of the FSHR-LUC constructs together with 50-150 ng of AHR and ARNT expression vectors (see Results for details), using either TurboFect in vitro transfection reagent (Fermentas) for KK-1 cells or FuGENE 6 transfection reagent (Roche Diagnostics, Mannheim, Germany) for primary cells as described in the manufacturers' manuals. All transfection mixtures were brought to the same amount of total DNA by the addition of the appropriate amount of empty vector. As a control for transfection efficiency, 50 ng of a pSV-b-galactosidase control vector (pSV-b-gal) (Promega) was also included. The activities of both luciferase and b-gal were determined 48 h after transfection, with the Dual Light reporter assay system (Applied Biosystems, Bedford, MA) following the manufacturer's protocol and analyzed with a GloMax 20/20 luminometer (Promega) with an automatic injector. Expression of luciferase in relative luciferase units was normalized to the b-gal control and expressed as a ratio. Results shown are mean fold changes in relative luciferase activity with respect to control (empty pcDNA3 vector).
Preparation of Nuclear and Cytoplasmic Extracts
Cells were collected, washed with PBS, and lysed using ProteoJET cytoplasmic and nuclear protein extraction kit (Fermentas) according to supplier's protocol. Briefly, cells were homogenized in ice-cold lysis buffer (supplemented with 1% protease inhibitor cocktail, P8340; Sigma-Aldrich, St. Louis, MO). After the homogenate was incubated for 10 min on ice, the samples were centrifuged (at 750 3 g) to collect the supernatant as the cytosolic extracts, and the final pellet was incubated in an equal volume (relative to the cytosolic extract) of nuclei lysis reagent. After incubating for 15 min at 48C with shaking on a Thermomixer (Eppendorf, Hamburg, Germany), the extract was spun for 20 min at 18 600 3 g, and the supernatant was used as nuclear extract. When necessary, protein concentrations of these extracts were determined using Bradford reagent (Fermentas).
DNA Affinity Precipitation Assay
Binding of nuclear AHR to DNA motifs in Fshr promoter was assessed in vitro by using a modified DNA affinity precipitation assay (DAPA) protocol based on that described by Dong et al. [24] . The 5 0 -biotinylated sense and nonbiotinylated antisense oligonucleotides (Table 1) corresponding to the region containing wild-type E-box/AP-1 binding sites (E-box/AP-1 probe) and their mutants (E-box mt probe and AP-1 mt probe) and to the putative XRE binding site (XRE probe) of the Fshr promoter were synthesized and HPLCpurified by Metabion (Martinsried, Germany). These were annealed by heating at 808C for 15 min, followed by a slow cooling to room temperature. For competition assays, a 10-fold molar excess of nonbiotinylated double-stranded consensus XRE (corresponding to mouse DRE3 [7] sequence), consensus USF1, or consensus AP-1 was included in the binding reaction mixture. Unlabeled E-box/AP-1 probe was used as negative control. DAPA reactions were performed as follows: equal amounts of nuclear protein (25 lg) were mixed with 0.4 lg of specific biotinylated DNA probes and 2 lg of poly(dI-dC) (P4929; Sigma-Aldrich) as a nonspecific competitor in 200 ll of binding buffer (60 mM KCl, 12 mM HEPES, pH 7.9, 4 mM Tris, 5% glycerol, 0.5 mM ethylenediaminetetraacetic acid, 1 mM dithiothreitol, 0.05% nonyl phenoxypolyethoxylethanol (NP-40), and protease inhibitor cocktail) and then incubated with gentle rotation either for 1 h at room temperature or overnight at 48C. DNA/protein complexes were then incubated with 20 ll of a 50% slurry containing streptavidin-agarose (Novagen, Nottingham, U.K.) on rotator for an additional 1 h at 48C. The affinity precipitates were recovered by centrifugation for 1 min at 3500 3 g, washed four times with ice-cold PBS, boiled in 13 SDS sample buffer (Fermentas), and subjected to protein analysis by SDS-PAGE.
SDS-PAGE and Immunoblot Analysis
Granulosa cell fractions and streptavidin-agarose affinity precipitates were resolved on 7.5% polyacrylamide-SDS gels. After electrophoresis, proteins were transferred to polyvinylidene fluoride membrane (Thermo Scientific, Rockford, IL) and blocked in 5% non-fat milk in TBST (20 mM Tris, 0.5 M NaCl, 0.1% Tween 20, pH 7.5). The blots were cut into pieces and probed with anti-AHR and anti-USF1 antibody by using a 1:5000 dilution in TBST-milk overnight at 48C. In addition, anti-RNA polymerase II IgG was used as quality control for fractionation (i.e., nuclear fractionation efficiency was indicated by the absence of the nuclear marker protein RNA polymerase II in the cytoplasmic extracts). Cytoplasmic levels of AHR were normalized using anti-actin antibody. Goat anti-rabbit or anti-mouse horseradish peroxidaseconjugated secondary IgGs (Thermo Scientific) were applied to visualize bound primary antibodies with the Western chemiluminescent horseradish peroxidase substrate (Immobilon, Billerica, MA).
Data Analysis
Statistical analyses were performed using the ANOVA test. Data were expressed as means 6 SEM. Statistical significance was assigned at a P value of 0.05.
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RESULTS
AHR Overexpression Enhances Fshr Reporter Gene Activity
Based upon published data showing that Ahr KO mice have reduced Fshr mRNA levels, our initial goal was to set up the model in order to closely study the mechanism behind this phenomenon. To this end, we first constructed CA-AHR and verified its functionality by using a luciferase reporter vector (pAhRDtkLuc3) containing three repeats of the XRE (data not shown). We then sought to determine whether CA-AHR is able to regulate the activity of transiently transfected Fshr promoter reporter. For this purpose, KK-1 granulosa cells were transiently transfected with pcDNA3, CA-AHR, and FSHR-1553-LUC (which contains the 5 0 flanking region in the mouse Fshr promoter from À1553 to À1 bp). As a result, cells overexpressing CA-AHR exhibited enhanced Fshr promoter reporter activity in a dose-dependent manner (Fig. 1A) . These data indicate that AHR is capable of positively influencing Fshr transcription by regulating its promoter activity.
Requirement of ARNT for AHR-Mediated Effects
It is well established that the formation of an AHR/ARNT transcription factor complex is necessary for dioxin-mediated XRE-driven target gene expression. In our initial experiments with KK-1 cells (Fig. 1A) , we coexpressed CA-AHR with ARNT. To analyze whether ARNT had any influence on the outcome, we performed additional experiments with either vector alone or both vectors together. Ectopic CA-AHR expression alone resulted in significant transactivation from the Fshr reporter genes (FSHR-1553-LUC and FSHR-209-LUC), and even higher activity was achieved if CA-AHR was transfected along with ARNT (Fig. 1B) . In contrast, the ARNT expression vector alone had no effect. These data are consistent with the idea that for AHR-dependent transcription of the Fshr gene, recruitment of ARNT (or ARNT-like protein) may be necessary in granulosa cells.
Region Between À209 and À99 bp Is Sufficient for AHR Transactivation
To define the region responsible for AHR activation of the Fshr promoter, cells were transiently cotransfected for 48 h with 5 0 sequential deletion constructs (À1553/À1-LUC, À562/ À1-LUC, À209/À1-LUC, or À99/À1-LUC) of the mouse Fshr promoter cloned into the promoterless pGL3-Basic luciferase reporter plasmid and an empty expression vector or an expression vector coding for CA-AHR (plus an equimolar amount of ARNT plasmid). As shown in Fig. 2 , KK-1 and primary granulosa cells transfected with À209/À1-LUC construct were fully responsive to CA-AHR. A complete loss of CA-AHR responsiveness occurred with À99/À1-LUC construct, implying essential regulatory sequences were present in this region (À209 to À99 bp).
AHR Regulates Fshr Promoter Activity Through an E-box Binding Site
To identify cis-acting elements needed for AHR's capability to act as a transcriptional activator, we took advantage of the presence of two known sites (AP-1 binding site and E-box) situated between À209 and À99 bp but also one putative XREbinding site. These sites are shown in Fig. 3A . To assess their functional importance, we performed mutations of the indicated sites within the Fshr promoter (À1553 to À1bp) reporter plasmid. These mutated vectors were then transfected into primary granulosa cells along with either CA-AHR (plus an equimolar amount of ARNT plasmid) or control vector (pcDNA3), and after incubating for 48 h, reporter luciferase activities were measured. We found that in contrast to AP-1 and XRE mutations, where no fold changes in response to CA-AHR overexpression were observed compared to that of wildtype vector, disruption of the E-box binding site decreased reporter activity to the level of that of the empty vector (Fig.  3B, lower panel) . The effects of mutations of these transcription factor-binding sites were found to be qualitatively similar in KK-1 cells (Fig. 3B, upper panel) . These data indicate that AHR-stimulated transcriptional activation is impaired on E-box mutant Fshr promoter.
AHR Binds to the E-box DNA-Binding Site but Not to the Putative XRE-Binding Site In Vitro Our results from transient transfection studies indicated that the E-box binding site is critically involved in AHR-dependent Fshr gene expression. To investigate the molecular mechanism by which AHR recognizes the Fshr promoter at this motif, we performed in vitro DNA binding studies by DAPA. It is well known that by binding to its E-box DNA element, the transcription factor USF1 plays a central role in the transcriptional regulation of the Fshr gene in mouse. Thus, we considered it possible that the AHR binds either directly to DNA or indirectly via USF1, and consequently, the influence of AHR binding to USF1 was assessed.
However, in order to prepare nuclear lysates for this assay, we first had to find out if there was any AHR in this cellular fraction in our cells. According to a long-established mechanism, unliganded AHR resides in the cytoplasm and exposure to TCDD, for example, triggers the migration of AHR to the cell nucleus. Therefore, we anticipated that if necessary, it is possible to induce AHR translocation into the nucleus by applying TCDD. Cell fractionation into nuclear and cytoplasmic components followed by Western blotting analysis revealed that no nuclear AHR bands on blots were apparent in KK-1 cells (Fig. 4A, lane 3) . However, following treatment of these cells with 10 nM TCDD for 1.5 h, the AHR was exclusively located within the nucleus (Fig. 4A, lane 4) . In contrast to the KK-1 cell line, in primary granulosa cells, we found that a certain amount of the AHR, although relatively small, was situated in the nuclear fraction of nontreated cells (Fig. 4A, lane 7) . Moreover, we observed that TCDD caused only a small proportion of AHR to move to the nucleus (Fig.  4A, lane 8) . Nuclear fractionation efficiency is indicated by the fact that the nuclear marker protein RNA polymerase II was very light to absent (KK-1) or almost absent (primary cells) in the cytoplasmic extracts. Thus, to prepare nuclear extracts from KK-1 and primary granulosa cells, they were first treated with or without TCDD, respectively, and then proteins from nuclear preparations were subjected to DAPA using 5 0 -biotin-labeled wild-type and mutant oligonucleotides harboring E-box, AP-1, and putative XRE binding sites of Fshr promoter as probes.
Following precipitation of DNA/protein complexes from KK-1 extracts, examination of Western blots showed that both AHR and USF1 bind to the wild-type E-box/AP-1 probe (Fig.  4B, lane 1) . No binding, however, was observed when precipitation with the mutated probe (E-box mt) was used (Fig. 4B, lane 2) . When putative XRE probe was used, neither AHR nor USF1 binding was seen (Fig. 4B, lane 3) , whereas no interference in binding was revealed for probe with the mutated AP-1 motif (AP-1 mt) (Fig. 4B, lane 5) . Although these results demonstrate association between AHR and the E-box binding site, they do not allow a conclusion to be drawn about whether TEINO ET AL. 0 -biotin-labeled DNA probes corresponding to Fshr E-box/AP-1 and XRE motifs, alone or together with excess nonbiotinylated consensus XRE, USF1, or AP-1 competitors. Binding of AHR and USF1 proteins to these wild-type probes was detected by Western blotting. A representative immunoblot of two independent experiments is shown. C) DAPA of primary granulosa cells was performed essentially in the same way as described for KK-1 cells (except that no pretreatment with TCDD was made for nuclear fractionation).
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it takes place through USF1-dependent complex formation. To control this, a nonbiotinylated oligonucleotide containing the consensus USF1 binding motif (USF1_comp) was supplied in 103 excess to the reaction mixture, which prevents binding of USF1 to probe via competition. As a result, this caused the disappearance of the USF1 band while it left the AHR band essentially unchanged (Fig. 4B, lane 7) . As expected, when excess XRE competitor (XRE_comp) was used, no binding of AHR to probe was observed. In contrast, no change in binding of USF1 was noticed (Fig. 4B, lane 6 ), indicating that AHR had no impact on its binding. Binding specificity was verified by incubating lysate with unlabeled ''cold'' E-box probe (Fig.  4B, lane 9) and with streptavidin-agarose beads only (Fig. 4B,  lane 10) . The upper and lower panels in Figure 4B , lane 11, represent Western blots of an aliquot of nuclear extract taken prior to DAPA and probed with AHR and USF1 antibodies, respectively.
When we applied nuclear extracts of primary granulosa cells, our findings resembled those of KK-1 cells, i.e., there was binding of AHR and USF1 to the wild-type E-box/AP-1 probes (Fig. 4C, lane 1) but not to the mutated probe (Fig. 4C,  lane 2) , whereas the use of competitor-displaced USF1 but not AHR (Fig. 4C, lane 4) . Altogether, our data, which show that binding of USF1 to Fshr DNA probe is not necessary to precipitate AHR, support the notion of direct AHR binding to DNA rather than protein-protein interaction with USF1.
AHR Mutants Defective in DNA Binding Do Not Bind to or Transactivate Fshr Promoter
Next, we hypothesized that if the independence of AHR binding from the presence of USF1 were really correct, then in addition to the above findings, the AHR protein with a mutation that prevents its binding to DNA should be unable to bind to or activate Fshr promoter. To determine the importance of DNA binding in the AHR-mediated Fshr promoter activation, we constructed CA-AHR mutants (AHR_A78D and AHR_DBD) that were incapable of DNA binding, as described earlier [20, 21] . Upon this construction, KK-1 and primary granulosa cells were transfected with CA-AHR or its respective mutants (plus equimolar amounts of ARNT) or with empty vector, and nuclear or whole-cell lysates were used for DAPA or Fshr reporter gene activity measurements, respectively. Similar to our experiments using endogenous AHR (Fig.  4, B and C) , binding of wild-type CA-AHR and USF1 to the wild-type but not to the mutated Fshr promoter sequence was revealed by their respective antibodies (Fig. 5A, lane 1) and their absence when their specific DNA sequence was mutated (Fig. 5A, lane 2) . Importantly, however, unlike USF1, no binding of mutant CA-AHR to E-box/AP-1 probe could be seen if either AHR_A78D (Fig. 5A, lane 4) or AHR_DBD (Fig. 5A, lane 7) was ectopically expressed in KK-1 cells. To ensure that an equal amount of protein was used in each reaction, we immunoblotted aliquots of the lysate with AHR and USF1 antibodies (Fig. 5A, lanes 10-12) .
When reporter gene expression was monitored upon transfection of wild-type CA-AHR and ARNT cDNA, an increase in luciferase activity was observed relative to that of cells transfected with reporter alone, both in KK-1 and in primary granulosa cells (Fig. 5B) . In comparison, luciferase activity was markedly repressed in cells transfected with AHR_A78D or AHR_DBD compared to that in wild-type CA-AHR. Taken together, these results demonstrate that AHR binds directly to Fshr promoter DNA at the E-box element to exert its activity in granulosa cells and does not act via USF1.
Effect of the AHR Ligand TCDD on Mouse Fshr Promoter Activity
Recently, evidence for the effect of TCDD on the regulation of Fshr mRNA in cultured rat granulosa cells was presented [25] . The observed decrease of message levels by TCDD was shown to be brought about by transcriptional mechanisms. Hence, we were interested to find out whether similar regulation operates in mouse granulosa cells with respect to the ectopically expressed Fshr promoter-reporter gene. Primary granulosa cells were transfected with the FSHR-1553-LUC or FSHR-209-LUC reporter, either together with empty vector (pcDNA3) or with equal quantities of AHR and ARNT expression vectors. Twenty-four hours later, the cells were treated with 10 nM TCDD or an equal amount of DMSO until they were assayed for luciferase activity. When reporter gene expression was monitored upon treatment of cells with TCDD, a small increase in luciferase activity was observed relative to that in cells transfected with reporter alone (Fig. 6) . Much higher activity, however, was achieved in TCDD-treated cells that had been transfected beforehand with AHR and ARNT expression vectors.
DISCUSSION
It was previously known that AHR participates in regulation of the Fshr transcript level in mouse ovary by binding to the promoter of this gene in vivo [11] . However, molecular interactions at the Fshr promoter needed for this regulation were unknown. In this study, we have demonstrated that AHR is capable of positively influencing Fshr transcription by regulating its promoter activity through the region between À209 and À99 bp upstream of the translation start site. In this region, the importance of the E-box site was revealed by sitedirected mutagenesis followed by promoter function analysis. By focusing on DNA/protein interactions, we confirmed that intact E-box but not USF1, which is known to bind to this motif, is necessary for AHR binding to mouse Fshr promoter in vitro. Having defined the fact that AHR mutants incapable of DNA binding are unable to interact at the E-box, we concluded that the reduction in promoter activity in the transient transfections using the mutated E-box constructs was most likely due to a loss of DNA-AHR interaction caused by the Ebox mutations. Collectively, the present study expands previous findings, which elucidated the requirement of the AHR for mouse Fshr expression in vivo, by demonstrating the molecular interplay of the Fshr promoter involved in the transactivation by AHR.
In the current study, to delineate the intrinsic role of AHR in Fshr regulation, we used the CA-AHR, which lacks binding capacity for ligands and has constitutive transcriptional activity [17] . We thought it might have given us two advantages. First, the unliganded AHR, i.e., the AHR not activated by exogenous ligand, might be more suitable for defining its endogenous functions. For example, one previous study has shown that TCDD had an inhibitory role in respect to Fshr transcription [25] , thus suggesting that AHR, which is activated by exogenous ligand, can actually antagonize the stimulatory effect of unliganded AHR. Second, avoiding these chemicals is useful as they may exhibit AHR-independent adverse effects in granulosa cells. We are aware of the caveat of using CA-AHR, which may possibly differ from native AHR in respect to its ability to regulate Fshr. However, data presented in Fig. 6 , among others, yielded convincing results that with respect to the Fshr promoter, the native AHR harbored a transactivating potential mimicking that of CA-AHR. Of note, these were also TEINO ET AL. only reporter gene experiments, where we used wild-type AHR for the reason that the impact of its ligand status upon the Fshr promoter activity was explored.
Current understanding of Fshr transcription is derived largely from studies of rat, murine, and human Fshr genes, which focused on characterization of the 5 0 flanking region. Due to their predominant role with respect to Fshr transcription, the E-box and its binding proteins, USF1 and USF2, have received the greatest attention thus far [26] . USF1 and USF2 are members of the helix-loop-helix family that form both Thereafter, DAPA was performed by hybridizing nuclear extracts prepared from transfected KK-1 cells with biotinylated wild-type E-box/AP-1 probe (Ebox), or mutant oligomer devoid of E-box binding activity (E-box mt), or using excess cold consensus USF1 competitor (USF1_comp) together with biotinylated E-box/AP-1 probe. The avidin-precipitated protein complexes were analyzed by Western blotting with immunodetection of bound transcription factors, using antibodies against AHR and USF1. B) KK-1 and primary granulosa cells were cotransfected with luciferase construct containing the FSHR À209/-1 in pGL3 vector together with equal quantities of ARNT and AHR_A78D or AHR_DBD expression vectors. *P , 0.05 compared with control; ***P , 0.001.
Fshr TRANSACTIVATION BY AHR IS THROUGH AN E-BOX
homodimers (USF1 and USF2) and heterodimers (USF1/2), and evidence from studies in rodents document the fact that in ovary, homo-and heterodimers direct Fshr promoter activity equally well [16] .
Evidence about the part played by AHR in Fshr regulation first appeared in 2007 with the demonstration that AHR deletion leads to slow ovarian follicle growth in prepubertal mice, in part because of reduced FSH responsiveness [11] . This was in turn due to the ability of the AHR to regulate the Fshr transcript level, the data being consistent with the recruitment of AHR to Fshr proximal promoter as shown by chromatin immunoprecipitation (ChIP) assay. Further evidence from that group's studies suggested that AHR might play a role in regulating follicle growth in prepubertal mice but not in adult mice [27] . As a matter of fact, AHR's requirement for Fshr expression is not unexpected, given the increasingly established function of this receptor in the regulation of female reproduction, e.g., via expression of the Cyp19 gene encoding aromatase [28] . Our data showing that AHR response is located in the Fshr promoter region between À209 and À99 bp are in agreement with the approximate AHR binding region anticipated from ChIP data by Barnett and co-workers [11] .
The classical recognition motif of the AHR/ARNT complex, the XRE, contains the core consensus sequence 5 0 -TNGCGTG-3 0 , which is composed of two half-sites, TNG and GTG, which is recognized by AHR and ARNT, respectively [29] . According to prediction analysis by TFSEARCH software (available at http://www.cbrc.jp/research/db/TFSEARCH. html), unfortunately, the region important for AHR response (À209 to À99 bp) was not found to contain any AHR/ARNT binding motif(s). Based on visual examination of the sequence, however, there seemed to be a putative XRE site, À172 TTGCCTG À166 , located in the well-conserved region of the Fshr promoter and differing from the consensus by only one bp. However, as it turned out from both binding and transactivation studies, this site appears to be nonfunctional. In contrast, our study provides evidence for the necessity of the Ebox ( À124 CACGTG À119 ) in the regulation of Fshr by AHR, as site-directed mutagenesis of this site prevented the AHRmediated reporter gene activation from occurring. Importantly, the ARNT homodimers have been implicated in the gene regulation via E-box motif [30] . Hence, to be sure that the activation of the Fshr promoter, as seen in our reporter experiments, did not result from ARNT/ARNT complex, the effect of ARNT transfected alone was also tested. However, ARNT had effect only when overexpressed together with AHR, suggesting that most likely, the E-box was bound by the AHR/ARNT complex.
The findings by luciferase activity are in agreement with our in vitro DNA/protein interaction studies showing a binding of non-TCDD-bound AHR, TCDD-activated AHR, and CA-AHR to the intact but not to the mutated E-box probe containing a double point mutation in the core sequence (CAATTG; where underlined bases are mutated). These data differ from those of the classical model of AHR binding to XRE motif, in which AHR, following TCDD activation, is known to regulate the expression of, e.g., drug-metabolizing enzymes. However, the outcomes in the current work are consistent with those of a recent report demonstrating that AHR-controlled regulation of the IL17 promoter in Th17 cells is mediated by its binding to the E-box element [31] .
Transcriptional regulation of a transcription factor without DNA binding has been described previously for several transcription factors. There is also evidence that the ligandactivated AHR directly associates with, for example, estrogen receptor alpha to regulate transcription [32] . Therefore, we surmised that binding of AHR to Fshr promoter at E-box may be indirect, thus, by tethering to other DNA interacting transfactors (i.e., USF). This possibility seems especially likely given the proven role of USFs in Fshr regulation through an Ebox. Thus, to determine the importance of DNA binding in AHR-mediated Fshr promoter activation, we constructed two CA-AHR mutants (AHR_A78D and AHR_DBD) not capable of DNA binding and then assessed their ability to bind to and activate Fshr promoter in vitro. Taking the results together, the mutations introduced disrupted AHR interaction with E-box and prevented Fshr promoter activity, meaning that direct DNA binding is necessary for AHR mediation of Fshr gene transactivation. We cannot totally exclude the possibility that the inability of CA-AHR mutants to bind to the E-box probe was not due to the defective DNA binding but instead may have been caused by impairment of USF1 binding. However, in support of the previous observations, in DNA affinity precipitation reactions, the presence of excess unlabeled USF1 competitor (USF1_comp) competed out binding of USF1 but not AHR to a biotin-labeled E-box probe, clearly signifying that AHR is in fact able to bind E-box independently of USF1.
Notably, this latter finding emphasizes that, apart from the E-box core sequence, flanking nucleotides are of importance. The fact that USF1_comp differs from Fshr E-box probe by having G and C instead of A and T at the þ1 and þ3 positions downstream of the CACGTG site (Table 1) , respectively, indicates that flanking nucleotides may indeed have contributed to differences between AHR and USF1 in relation to competition by USF1_comp. Consistent with this, as previously reported [33, 34] , an A-to-G and A-to-C change at the first and third positions downstream of the GCGTG site, respectively, obliterate the function of dioxin-activated AHR as a transcriptional enhancer of its target genes. The significance of flanking bases has also been proven for binding of ARNT homodimers to E-box [29] . Therefore, we think that nucleotides that flank an E-box within Fshr promoter may be involved in dictating the affinity with which AHR/ARNT heterodimer interacts with this motif.
The coexistence of USF and AHR in granulosa cells raises the question of their simultaneous or mutually exclusive binding on the target DNA sequence. Our DNA/protein interaction studies do not allow us to conclude whether or not AHR and USF1 bind to the Fshr E-box probe simultaneously. To verify this, further experiments would needed. However, the use of the same recognition sequence in the Fshr promoter by both USF and AHR is suggestive of exclusive binding and alternate transactivation by these two factors. In addition, as it has recently been pointed out, two transcription factors with identical DNA-binding specificities may not necessarily compete for occupancy at a given DNA element, but instead, one factor can even facilitate the binding of another through the regulation of chromatin accessibility [35] . Therefore, we speculate that the alternative for competitive displacement would be the model by which AHR will actually assist the binding of USF to Fshr promoter. Some credibility to this could be given by the fact that AHR-mediated transactivation is known to be associated with chromatin remodeling [36] .
Finally, we tested whether AHR ligand, TCDD, has the ability to activate Fshr promoter in vitro. This is of particular interest considering that an earlier study in rat granulosa cells indicated that TCDD actually interferes with Fshr transcription. In this respect, one must notice that in the regulation of BRCA1 promoter activity, as documented by Hockings et al. [37] , exogenously activated AHR may antagonize the stimulatory effect of unliganded AHR by displacing coactivators and thus increasing the recruitment of HDAC1. Hence, by analogy, one might conceivably hypothesize that ligand status of the AHR may also be at work in modulating the activation of Fshr promoter. To get some insight into this matter, primary granulosa cells were transfected with the FSHR-LUC reporter and then treated with TCDD. To our surprise, however, no inhibition occurred, but, to the contrary, a stimulation of Fshr promoter was observed in response to TCDD. These data appear to contradict those published in studies with rats, which show the repressive effect of TCDD, indicating that there might be a species-specific effect. Alternatively, and maybe more likely, this outcome reflects the inability of the reporter gene model to recapitulate the molecular events required for adequate response to take place. At least it is clear that a mechanism similar to that described by Hockings et al. [37] could not operate for Fshr as no reporter inhibition was revealed after incubation with TCDD. Further studies are necessary to clarify the issue of what mechanism is responsible for the repression.
In conclusion, while current research focuses on identification of AHR's physiologic functions, a study like ours contributes to this effort by providing a clearer understanding of the intrinsic regulatory mechanism of AHR in controlling a significant aspect of reproduction, i.e., Fshr transcription. In this paper, we present new evidence that the AHR, likely in complex with ARNT, modulates Fshr promoter activity by its direct association through an E-box and not by recruitment via interaction with USFs. Hence, both USFs and AHR complexes are able to bind to the same E-box sequence. It is likely that AHR and USFs respond to different signals and compete on binding to the Fshr E-box depending on the physiological conditions in the cell. Importantly, these findings have led us to a novel insight regarding the transactivation of a gene by AHR via E-box, the motif previously not well recognized as a DNA binding sequence for AHR. Hence, there might be other (reproductive) genes regulated by AHR through E-boxes. From the perspective of environmental health, further studies are warranted for assessment of potential role of dioxin-like compounds to interfere with the expression of the Fshr gene, the gene encoding the receptor for one of the most important hormones involved in fertility.
